The path to personalized medicine.

@article{Hamburg2010ThePT,
  title={The path to personalized medicine.},
  author={Margaret A. Hamburg and Francis S. Collins},
  journal={The New England journal of medicine},
  year={2010},
  volume={363 4},
  pages={
          301-4
        }
}
Major investments in basic science have created an opportunity for significant progress in clinical medicine. Researchers have discovered hundreds of genes that harbor variations contributing to human illness, identified genetic variability in patients' responses to dozens of treatments, and begun to target the molecular causes of some diseases. In addition, scientists are developing and using diagnostic tests based on genetics or other molecular mechanisms to better predict patients' responses… 
Concern for Pharmacogenomics and Autologous Cell Therapy: Can This Be a Direction Toward Medicine for the Future?
TLDR
Individualized medicine has advanced because researchers have discovered hundreds of genes that harbor variations contributing to human illness and identified genetic variability in patients’ responses to dozens of treatments and have begun to target the molecular causes of some diseases.
Personalized genomic medicine
  • G. Novelli
  • Medicine
    Internal and emergency medicine
  • 2010
TLDR
Personalized medicine provide to physicians a molecular makeup of each patient, and medical professionals are able to select patients, and use the found information to plan out a course of treatment that is much more in step with the way their body works.
Addressing the gap between genetics knowledge and clinical practice: a pilot study to implement genetics education among physicians in Italy
TLDR
Hundreds of genes whose variations contribute to human diseases, or patients’ responses to drug treatments or even to vaccination have been discovered, laying the foundation for a paradigm shift in healthcare.
Pharmacogenomics and Individualized Medicine: Translating Science Into Practice
TLDR
Key components to successful clinical implementation of pharmacogenomics will include consistent interpretation of Pharmacogenomics test results, availability of clinical guidelines for prescribing on the basis of testresults, and knowledge‐based decision support systems.
Personalized medicine and blood disorders.
  • Li Zhang
  • Medicine, Biology
    Personalized medicine
  • 2016
TLDR
The available data suggest that the ability to understand the clinical features of a patient's genetic profile and the knowledge of disease mechanisms are the keys to facilitate new diagnosis, new therapies, new prescriptions and better healthcare.
Personalized medicine for cystic fibrosis: the next generation.
TLDR
Some of the opportunities and challenges associated with developing novel genotype-directed therapies for cystic fibrosis are highlighted.
Genomic medicine: new frontiers and new challenges.
TLDR
It is now clear that personalized Medicine will not immediately provide a permanent solution for patient management and that further refinement in the applications of personalized medicine will be needed to address and focus on specific issues.
...
1
2
3
4
5
...

References

Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use
Study Objectives. To review the labels of United States Food and Drug Administration (FDA)‐approved drugs to identify those that contain pharmacogenomic biomarker information, and to collect